These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 9872320)

  • 1. An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation.
    Manoury B; Hewitt EW; Morrice N; Dando PM; Barrett AJ; Watts C
    Nature; 1998 Dec; 396(6712):695-9. PubMed ID: 9872320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct protease requirements for antigen presentation in vitro and in vivo.
    Matthews SP; Werber I; Deussing J; Peters C; Reinheckel T; Watts C
    J Immunol; 2010 Mar; 184(5):2423-31. PubMed ID: 20164435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel cell-permeable acyloxymethylketone inhibitors of asparaginyl endopeptidase.
    Loak K; Li DN; Manoury B; Billson J; Morton F; Hewitt E; Watts C
    Biol Chem; 2003 Aug; 384(8):1239-46. PubMed ID: 12974392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of legumain.
    Schwarz G; Brandenburg J; Reich M; Burster T; Driessen C; Kalbacher H
    Biol Chem; 2002 Nov; 383(11):1813-6. PubMed ID: 12530547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asparaginyl endopeptidase: case history of a class II MHC compartment protease.
    Watts C; Matthews SP; Mazzeo D; Manoury B; Moss CX
    Immunol Rev; 2005 Oct; 207():218-28. PubMed ID: 16181339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human B lymphoblastoid cells contain distinct patterns of cathepsin activity in endocytic compartments and regulate MHC class II transport in a cathepsin S-independent manner.
    Lautwein A; Kraus M; Reich M; Burster T; Brandenburg J; Overkleeft HS; Schwarz G; Kammer W; Weber E; Kalbacher H; Nordheim A; Driessen C
    J Leukoc Biol; 2004 May; 75(5):844-55. PubMed ID: 14966190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bm-CPI-2, a cystatin from Brugia malayi nematode parasites, differs from Caenorhabditis elegans cystatins in a specific site mediating inhibition of the antigen-processing enzyme AEP.
    Murray J; Manoury B; Balic A; Watts C; Maizels RM
    Mol Biochem Parasitol; 2005 Feb; 139(2):197-203. PubMed ID: 15664654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bm-CPI-2, a cystatin homolog secreted by the filarial parasite Brugia malayi, inhibits class II MHC-restricted antigen processing.
    Manoury B; Gregory WF; Maizels RM; Watts C
    Curr Biol; 2001 Mar; 11(6):447-51. PubMed ID: 11301256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement C3b fragment covalently linked to tetanus toxin increases lysosomal sodium dodecyl sulfate-stable HLA-DR dimer production.
    Serra VA; Cretin F; Pépin E; Gabert FM; Marche PN
    Eur J Immunol; 1997 Oct; 27(10):2673-9. PubMed ID: 9368625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP.
    Manoury B; Mazzeo D; Fugger L; Viner N; Ponsford M; Streeter H; Mazza G; Wraith DC; Watts C
    Nat Immunol; 2002 Feb; 3(2):169-74. PubMed ID: 11812994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pig kidney legumain: an asparaginyl endopeptidase with restricted specificity.
    Dando PM; Fortunato M; Smith L; Knight CG; McKendrick JE; Barrett AJ
    Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):743-9. PubMed ID: 10215615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysosomal cysteine and aspartic proteases are heterogeneously expressed and act redundantly to initiate human invariant chain degradation.
    Costantino CM; Hang HC; Kent SC; Hafler DA; Ploegh HL
    J Immunol; 2008 Mar; 180(5):2876-85. PubMed ID: 18292509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of legumain, an asparaginyl endopeptidase that controls antigen processing, is reduced in endotoxin-tolerant monocytes.
    Wolk K; Grütz G; Witte K; Volk HD; Sabat R
    Genes Immun; 2005 Aug; 6(5):452-6. PubMed ID: 15875056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Destructive potential of the aspartyl protease cathepsin D in MHC class II-restricted antigen processing.
    Moss CX; Villadangos JA; Watts C
    Eur J Immunol; 2005 Dec; 35(12):3442-51. PubMed ID: 16259009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural processing sites for human cathepsin E and cathepsin D in tetanus toxin: implications for T cell epitope generation.
    Hewitt EW; Treumann A; Morrice N; Tatnell PJ; Kay J; Watts C
    J Immunol; 1997 Nov; 159(10):4693-9. PubMed ID: 9366392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cysteine cathepsins in the immune response.
    Zavasnik-Bergant T; Turk B
    Tissue Antigens; 2006 May; 67(5):349-55. PubMed ID: 16671941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asparagine deamidation perturbs antigen presentation on class II major histocompatibility complex molecules.
    Moss CX; Matthews SP; Lamont DJ; Watts C
    J Biol Chem; 2005 May; 280(18):18498-503. PubMed ID: 15749706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of antigen presentation by a single protease cleavage site.
    Antoniou AN; Blackwood SL; Mazzeo D; Watts C
    Immunity; 2000 Apr; 12(4):391-8. PubMed ID: 10795737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The proteasome activator 11 S REG (PA28) and class I antigen presentation.
    Rechsteiner M; Realini C; Ustrell V
    Biochem J; 2000 Jan; 345 Pt 1(Pt 1):1-15. PubMed ID: 10600633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific cathepsin B inhibitor is cell-permeable and activates presentation of TTC in primary human dendritic cells.
    Reich M; Wieczerzak E; Jankowska E; Palesch D; Boehm BO; Burster T
    Immunol Lett; 2009 Apr; 123(2):155-9. PubMed ID: 19428564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.